David Barrett Laboratory

Ongoing Research

Researchers at the Center for Childhood Cancer Research have shown that early lineage T cell enrichment can help to improve and expand the use of engineered T cell immunotherapies.

Research is underway to determine how to prevent cytokine release syndrome, a side effect of CART-19 therapy.